| Ticker Details |
Amgen Inc.
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
|
| IPO Date: |
January 2, 1990 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$183.12B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.47 | 1.00%
|
| Avg Daily Range (30 D): |
$3.62 | 1.07%
|
| Avg Daily Range (90 D): |
$4.05 | 1.15%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
4.72M |
| Avg Daily Volume (30 D): |
1.79M |
| Avg Daily Volume (90 D): |
1.92M |
| Trade Size |
| Avg Trade Size (Sh.): |
128 |
| Avg Trade Size (Sh.) (30 D): |
32 |
| Avg Trade Size (Sh.) (90 D): |
31 |
| Institutional Trades |
| Total Institutional Trades: |
115,165 |
| Avg Institutional Trade: |
$6.64M |
| Avg Institutional Trade (30 D): |
$41.73M |
| Avg Institutional Trade (90 D): |
$41.89M |
| Avg Institutional Trade Volume: |
.06M |
| Avg Institutional Trades (Per Day): |
20 |
| Market Closing Trades |
| Avg Closing Trade: |
$69.03M |
| Avg Closing Trade (30 D): |
$190.12M |
| Avg Closing Trade (90 D): |
$211.96M |
| Avg Closing Volume: |
393.7K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$14.48
|
$3.37
|
$2.47
|
|
Diluted EPS
|
$14.38
|
$3.34
|
$2.46
|
|
Revenue
|
$37.22B
|
$8.62B
|
$9.87B
|
|
Gross Profit
|
$25.41B
|
$5.87B
|
$6.89B
|
|
Net Income / Loss
|
$7.8B
|
$1.82B
|
$1.33B
|
|
Operating Income / Loss
|
$10.57B
|
$2.67B
|
$2.72B
|
|
Cost of Revenue
|
$11.81B
|
$2.74B
|
$2.98B
|
|
Net Cash Flow
|
$3.23B
|
$2.91B
|
$-316M
|
|
PE Ratio
|
|
|
|
|
|
|
